EXOZ eXoZymes Inc.

NASDAQ
$3.99

eXoZymes Inc. (EXOZ) is expected to report earnings on February 12, 2027, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of -2.7% since its last earnings release on November 13, 2026.

eXoZymes Reported Earnings
Friday, November 13, 2026 · 7:20 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 12
Friday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.89

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About eXoZymes Inc.

Invizyne Technologies Inc. is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc. is based in Monrovia, CA.

Charts powered in part by Lightweight Charts™ by TradingView.